Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trial

IFI demonstrated similar treatment efficacy to ENI in CCRT of ESCC. The HD demonstrated improved PFS, but did not significantly improve OS. The dose escalation based on IFI (HD+IFI) showed better therapeutic efficacy than the current recommendation (SD+ENI) and is worth further validation.

Authors

Institutions

Publication Details

Journal
Cancer Communications
Published
2024-08-19
DOI
https://doi.org/10.1002/cac2.12601
Citations
10
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
5.73

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trial

Hong Ge, Weidong Mao, Jundong Zhou, Xin Yuan et al.
10 citations
Cancer Communications
Esophageal Cancer Research and Treatment
5.73
article

Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trial

Hong Ge, Weidong Mao, Jundong Zhou, Xin Yuan, Kaixian Zhang, Heyi Gong, Gaowa Siqin, Juan Pu, Shucheng Ye, Haiqun Lin, Richard Man Kit Yu, Zhongtang Wang, Xiangdong Sun, Shengbin Dai, Fei Gao, Yunwei Han, Shaoshui Chen, Dai Mingming, Tao Zhou, Minghao Li, Liping Liu, Guang Li, Xiaomin Li, Jie Li, Xinchen Sun, Baosheng Li, Hongsheng Li, Jian Zhang, Lihua Dong, Xianwen Zhang, Anping Zheng, Yongjing Yang, Yanxing Sheng, Xiangming Chen, Wendong Gu, Xiaolin Ge, Haiwen Zhu, Wei Huang, Zhenjiang Li, Qingsong Pang, Xiaowei Liu, Jun Wang
article en
10 citations

Abstract

IFI demonstrated similar treatment efficacy to ENI in CCRT of ESCC. The HD demonstrated improved PFS, but did not significantly improve OS. The dose escalation based on IFI (HD+IFI) showed better therapeutic efficacy than the current recommendation (SD+ENI) and is worth further validation.

Cancer CommunicationsVol. 44(10)
Hebei Medical University (CN), Binzhou Medical University (CN), Shandong University of Aeronautics (CN), Nantong University (CN), Nanjing General Hospital of Nanjing Military Command (CN), Tianjin Medical University Cancer Institute and Hospital (CN), Zhengzhou University (CN), Soochow University (CN), Affiliated Hospital of Southwest Medical University (CN), First Affiliated Hospital of Xiamen University (CN), Huaian First People’s Hospital (CN), Jilin Province Tumor Hospital (CN), Shandong Tumor Hospital (CN), Shanxi Provincial Cancer Hospital (CN), Jiangyin People's Hospital (CN), Second Hospital of Shandong University (CN), Fourth Hospital of Hebei Medical University (CN), Jinan Central Hospital (CN), Taixing People's Hospital (CN), Suzhou Municipal Hospital (CN), The Affiliated Taizhou People's Hospital of Nanjing Medical University (CN), Inner Mongolia People's Hospital (CN), Yancheng Third People's Hospital (CN), Inner Mongolia Medical College Hospital (CN), Jining First People's Hospital (CN), Tengzhou Central People's Hospital (CN), Northern Jiangsu People's Hospital (CN), First Hospital of China Medical University (CN), Henan Cancer Hospital (CN), First Bethune Hospital of Jilin University (CN), Jiangsu Province Hospital (CN), Taian City Central Hospital (CN), Liaocheng People's Hospital (CN), Affiliated Hospital of Jining Medical University (CN), Anyang Tumor Hospital (CN), Shandong First Medical University (CN), Inner Mongolia Medical University (CN), Yangzhou University (CN), Nanjing Medical University (CN), Nanjing University (CN), China Medical University (CN)
National Natural Science Foundation of China, Shandong First Medical University, Key Technology Research and Development Program of Shandong
Good health and well-being
Openalex Percentile: Top 3%
Esophageal Cancer Research and Treatment
5.73
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.